The Caliciviruses Section addresses the role of human caliciviruses in human disease, with a focus on the development of prevention and control strategies for the noroviruses.
Kim Green, Ph.D.
Chief, Caliciviruses Section
Education:
Ph.D., The University of Tennessee Health Science Center (UTHSC), Memphis, Tennessee
Natthawan Chaimongkol, Ph.D.
Postdoctoral Fellow
Education:
Ph.D., Graduate School of Medicine, 2013, Tohoku University, Japan
Languages Spoken: Thai
My research focuses on preventing and controlling viruses that cause diarrhea, with a specialty in noroviruses. The research aims to understand the molecular mechanisms responsible for shifts in the epidemiology and pathogenesis of the virus. My expertise includes diagnostic assay development, molecular epidemiology, evolutionary dynamics of noroviruses, and the improvement of stem cell-derived...
Yuki Matsushima, Ph.D.
Postdoctoral Fellow
Education:
Ph.D., School of Medicine, 2017, Yokohama City University, Japan
Languages Spoken: Japanese
Former Research Group Members
Former Postdoctoral Trainees:
2000-2005, Gaël Belliot
Centre Hospitalier Universitaire, Dijon FR
2002-2005, Kyeong-OK Chang
Professor, Virology
Kansas State University School of Veterinary Medicine
2006-2013, Karin Bok, Ph.D.
Acting Deputy Director
Pandemic Preparedness and Emergency Response
VRC, NIAID, National Institutes of Health
2009-2016, Gabriel I. Parra, Ph.D.
Principal Investigator
Office of Vaccines Research and Review
DVP/FDA
2014-2017, Dennise De Jesus Diaz, Ph.D.
Chief Operations Officer
Remedy Plan Therapeutics
2014-2019, Eric Levenson, Ph.D.
Staff Fellow CBER/FDA